Come on in! Join Pinterest only takes like a second or so.

Cancer Clinical Trials

Human cancer clinical trials offer hope to cancer patients all over the world. The Gateway funds many phase I and phase II cancer clinical trials in all types of cancer. Learn more... it just may save a life!

Blood Cancer: Graft vs. Host Disease - a clinical trial by Dr. Corey Cutler, at the Dana Farber Cancer Institute at Harvard. Learn more about Dr. Cutler's clinical trial for the prevention and treatment of the graft vs. host disease for many bone marrow transplant patients.

Vaccines are usually associated with prevention, but Dr. Emens’ research uses innovative vaccines to treat breast cancer patients. Dr. Emens’ approach focuses on genetically modifying breast cancer cells to secrete granulocyte-macrophage colony-stimulating factor (GM-CSF), irradiating them, and then injecting them under the patient’s skin. This specialized vaccine stimulates the production of dendritic cells, the “orchestra leaders” of the immune system in recognizing and combating danger.

Combination therapy for advanced non-small cell lung cancer - a radically novel, cost-effective, and personalized approach to attack lung cancer by Dr. Richard Pietras. Learn more...

Powerful new tools for battling Myeloma - blood cancer, a phase II cancer clinical trial by Dr. Avigan. Dr. Avigan and his team at Beth Israel Deaconess Medical Center and the Dana Farber/Harvard Cancer Center, have begun new research to provide patients with an extra cancer-fighting antibody that amplifies the body’s immune response in its quest for a disease-free state. This research potentially creates a new option for maximizing the effectiveness of healthy T cells that act like soldiers des

Colorectal cancer is one of the deadliest cancers. Worldwide, over one million people are expected to be diagnosed with colon cancer in 2012. Half will die. Learn about the promising colon cancer clinical trial by Dr. Edward Lin - a prominent researcher at the Fred Hutchinson Cancer Center.